Lyell Immunopharma Inc (LYEL) stock news · rev $36.0K
Lyell Immunopharma Inc (LYEL) is a biotechnology company listed on US.
This LYEL news page leads with what Lyell Immunopharma Inc filed — not a scraped headline mill.
No cached 8-K sentence for LYEL yet. We will not pad this page with generic market recap.
Latest reported LYEL revenue for 2025-12-31 was $36.0K. Net income was -$274.4M. Revenue was down 41.0% from 2024-12-31 to 2025-12-31. LYEL currently screens at market cap $143.5M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the LYEL stock page; for the tape open the quote page.
LYEL stock news FAQ
What are LYEL's latest revenue and net income?
Latest cached Lyell Immunopharma Inc (LYEL) revenue for Dec 31, 2025 was $36.0K. Net income was -$274.4M. Statements: https://lician.com/financials/lyel
How did LYEL revenue change from the prior cached period?
Cached Lyell Immunopharma Inc (LYEL) revenue was down 41.0% from $61.0K (Dec 31, 2024) to $36.0K (Dec 31, 2025). Statements: https://lician.com/financials/lyel
What is LYEL's market cap?
Lyell Immunopharma Inc (LYEL) market cap is $143.5M on the latest cached fundamentals snapshot.
What kind of company is LYEL?
Lyell Immunopharma Inc (LYEL) is a biotechnology company listed on US.
Where is LYEL stock news listed?
Cached stock news for Lyell Immunopharma Inc (LYEL) is listed at https://lician.com/news/lyel. Filings: https://lician.com/sec/lyel
Not investment advice.